[go: up one dir, main page]

JPS5665829A - Antitumor agent - Google Patents

Antitumor agent

Info

Publication number
JPS5665829A
JPS5665829A JP14215379A JP14215379A JPS5665829A JP S5665829 A JPS5665829 A JP S5665829A JP 14215379 A JP14215379 A JP 14215379A JP 14215379 A JP14215379 A JP 14215379A JP S5665829 A JPS5665829 A JP S5665829A
Authority
JP
Japan
Prior art keywords
antibody
antitumor
purity
tumor
purified
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP14215379A
Other languages
English (en)
Other versions
JPS6256137B2 (ja
Inventor
Chikao Yoshikumi
Takami Fujii
Masahiko Fujii
Kenichi Matsunaga
Yoshiharu Oguchi
Koichi Niimura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Priority to JP14215379A priority Critical patent/JPS5665829A/ja
Priority to US06/103,474 priority patent/US4315851A/en
Priority to SE7910483A priority patent/SE7910483L/xx
Priority to PH23447A priority patent/PH16902A/en
Priority to CH11501/79A priority patent/CH655010A5/de
Priority to GB7944494A priority patent/GB2038836B/en
Priority to FR797932054A priority patent/FR2445149B1/fr
Priority to DE2952690A priority patent/DE2952690C2/de
Priority to IT28464/79A priority patent/IT1127324B/it
Publication of JPS5665829A publication Critical patent/JPS5665829A/ja
Priority to US06/321,486 priority patent/US4401592A/en
Priority to SE8406511A priority patent/SE8406511L/xx
Priority to SE8406510A priority patent/SE8406510L/xx
Publication of JPS6256137B2 publication Critical patent/JPS6256137B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP14215379A 1978-12-29 1979-11-02 Antitumor agent Granted JPS5665829A (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
JP14215379A JPS5665829A (en) 1979-11-02 1979-11-02 Antitumor agent
US06/103,474 US4315851A (en) 1978-12-29 1979-12-14 Pharmaceutical composition having antitumor activity
SE7910483A SE7910483L (sv) 1978-12-29 1979-12-19 Farmaceutisk komposition med tumorhemmande effekt
PH23447A PH16902A (en) 1978-12-29 1979-12-20 Pharmaceutical composition having anti-tumor activity
CH11501/79A CH655010A5 (de) 1978-12-29 1979-12-28 Pharmazeutischer wirkstoff mit antitumoraktivitaet.
GB7944494A GB2038836B (en) 1978-12-29 1979-12-28 Antitumour substance
FR797932054A FR2445149B1 (fr) 1978-12-29 1979-12-28 Composition pharmaceutique ayant une activite antitumorale
DE2952690A DE2952690C2 (de) 1978-12-29 1979-12-29 Antitumorsubstanz, Verfahren zu ihrer Herstellung und diese enthaltendes pharmazeutisches Mittel
IT28464/79A IT1127324B (it) 1978-12-29 1979-12-31 Composizione farmaceutica avente attivita' antitumorale
US06/321,486 US4401592A (en) 1978-12-29 1981-11-16 Pharmaceutical composition having antitumor activity
SE8406511A SE8406511L (sv) 1978-12-29 1984-12-20 Farmaceutisk komposition med tumorhemmande effekt
SE8406510A SE8406510L (sv) 1978-12-29 1984-12-20 Farmaceutisk komposition med tumorhemmande effekt

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14215379A JPS5665829A (en) 1979-11-02 1979-11-02 Antitumor agent

Publications (2)

Publication Number Publication Date
JPS5665829A true JPS5665829A (en) 1981-06-03
JPS6256137B2 JPS6256137B2 (ja) 1987-11-24

Family

ID=15308586

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14215379A Granted JPS5665829A (en) 1978-12-29 1979-11-02 Antitumor agent

Country Status (1)

Country Link
JP (1) JPS5665829A (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142124A (ja) * 1983-04-08 1987-06-25 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01257331A (ja) * 1987-12-10 1989-10-13 Fuji Electric Co Ltd マイクロ波整合装置とマイクロ波整合方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962194A (ja) * 1972-05-10 1974-06-17
JPS5161640A (en) * 1974-09-20 1976-05-28 Searle & Co Koshuyozaino seizoho
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4962194A (ja) * 1972-05-10 1974-06-17
JPS5161640A (en) * 1974-09-20 1976-05-28 Searle & Co Koshuyozaino seizoho
JPS51144723A (en) * 1975-05-27 1976-12-13 Yeda Res & Dev Antiitumor agent

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62142124A (ja) * 1983-04-08 1987-06-25 Kureha Chem Ind Co Ltd ヒト免疫グロブリン結合抗腫瘍剤
JPH0611714B2 (ja) * 1983-04-08 1994-02-16 呉羽化学工業株式会社 ヒト免疫グロブリン結合抗腫瘍剤

Also Published As

Publication number Publication date
JPS6256137B2 (ja) 1987-11-24

Similar Documents

Publication Publication Date Title
IT8223795A0 (it) Gamma), relativi veicoli di polipeptidi contenenti la sequenza espressione, loro procedimento di degli amminoacidi dell'interferone preparazione, composizioni umano immune (interferone umano farmaceutiche contenenti tali polipeptidi.
DK0458878T3 (da) Nyt monoklonalt antistof mod et nyt antigen, der er associeret med humane tumorer
HK1012841A1 (en) Pharmaceutical composition for the treatment or prevention of amalignant tumor
RU92016463A (ru) Применение производных цистина для изготовления лекарственных препаратов с иммуномоделирующим действием, фармацевтические композиции на их основе
AU3125289A (en) Monoclonal antibodies directed against human tumor necrosis factor - receptor
CA2098021A1 (en) Composition Used as a Therapeutic Agent Against Chronic Viral Hepatic Diseases
EP0147283A3 (en) Immunomodulating medicine based on fe fragments of human igg
CA2000913A1 (en) Family of high affinity antibodies for cancer treatment
Andrew et al. Secretion of a macrophage‐activating factor distinct from interferon‐γ by human T cell clones
EP0674661A4 (en) TITRATION AND TREATMENT FOR DEMYELINIZING DISEASES SUCH AS MULTIPLE SCLEROSIS.
IT8319160A0 (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi.
GR852541B (ja)
JPS5665829A (en) Antitumor agent
JPS5665828A (en) Antitumor agent
ES556684A0 (es) Un procedimiento para tratar celulas efectoras que tienen receptores de superficie para la region fc de un anticuerpo
JPS5592325A (en) Antitumor agent and its preparation
CA2308007A1 (en) Enhancer for antibody to lymphocytic tumors
FR2555755B1 (fr) Procede de dosage des immunoglobulines humaines qui sont specifiques d'antigenes cancereux humains et application de ce procede dans le serodiagnostic de maladies tumorales primitives
FI92716C (fi) Uudet monoklonaaliset vasta-aineet IFN-omegalle, niiden valmistusmenetelmät ja niiden käyttö IFN-omegan puhdistamiseen ja osoittamiseen
CA2002218A1 (en) Neoglycoproteins, the preparation and use thereof
CA2038030A1 (en) Synthetic peptides which contain sequences from factor viia, and the use thereof
RU94045008A (ru) Способ преодоления гематоэнцефалического барьера
JPS5780327A (en) Carcinostatic agent
FR2524315B1 (fr) Nouvel antigene pour la recherche de l'hypersensibilite cutanee brucellique notamment chez l'homme, et son procede de preparation
MatthewsA Secretion of a macrophage-activating factor distinct from interferon-y by human T cell clones